Where does BostonGene Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), BostonGene Corporation ranks #9,208 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does BostonGene Corporation hold?

BostonGene Corporation holds 34 US utility patents granted between 2019 and 2025, spanning 13 technology areas.

What is BostonGene Corporation's Innovation Score?

BostonGene Corporation has an Innovation Score of 42.7 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is BostonGene Corporation's patent grant rate increasing or decreasing?

BostonGene Corporation's recent grant velocity is +440% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for BostonGene Corporation's patents?

BostonGene Corporation's patents average 18.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the BostonGene Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

BostonGene Corporation

Q: What technology areas does BostonGene Corporation focus on?

BostonGene Corporation's top technology area is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology) with 26 patents, ranking #25 of 676 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 34 granted patents across 13 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bostongene ranks #9,208 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 13 technology areas.

#9,208
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.7/100): 18.3
avg claims per patent: +440%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9208 · US Corporation #9,208 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 34 grants
UPPER-Q #9,208/49,997
PHOTO-FINISH Blue-White Industries
CPC-FOCUS G16B · 13 areas
INNOV-PAR 42.7/100
CLAIMS-RICH 18.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +440% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Blue-White Industries, Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bostongene’s 42.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.3 pts (29%) Velocity 6.7 pts (16%) Breadth 12.7 pts (30%) Claim depth 11.0 pts (26%)

Qualcomm Incorporated · highest

85
Kose · near

43
Senior IP · near

43
Sharp Life Science… · near

43
BostonGene · this assignee

43
Hermes Innovations · near

43
3D Lighting… · lowest

7

What this shows Bostongene's Innovation Score is 42.7/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bostongene?

Each dot is one of Bostongene’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bostongene’s own 18.3 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bostongene vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bostongene's grants concentrate

BostonGene Corporation is a focused PatentsView assignee: 13 CPC subclasses with 76.5% of grants classified under G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology). Peak complete grant year is 2020 (10 grants) versus a trough of 1 in 2021. By volume, Bostongene sits between Blue-White Industries, Ltd. and Buffalo Filter LLC.

Bostongene's three-year grant acceleration

BostonGene Corporation shows 16 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Blue-white Indust…

34
Bluescope Steel

34
Board of Trustees…

34
Boomi

34
Bourgault Industr…

34
Brightcove

34
Buckingham Manufa…

34
Buffalo Filter

34
Bostongene ◀

34

What this shows BostonGene holds 34 patents at rank #9,208, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near BostonGene

By rank, the assignees closest to #9,208 in granted patent volume.

Leaders in G16B (Bioinformatics)

Other assignees with the most granted patents in BostonGene's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for BostonGene, neither rank-band nor same-CPC leaders (those blocks stay above). In G16B (Bioinformatics), BostonGene ranks #25 of 676 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Hermes Innovations, LLC 43 Kose Corporation 43 Sharp Life Science (EU) Limited 43 Senior IP GmbH 43

Bostongene's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

BostonGene Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	5	14.7%
2020	10	29.4%
2021	1	2.9%
2022	9	26.5%
2023	4	11.8%
2024	3	8.8%
2025partial year	2	5.9%

Which technologies does BostonGene Corporation patent most?

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 26

G06F - Electric Digital Data Processing 24

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 23

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 22

C07K - Peptides 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

G06V - Image OR Video Recognition OR Understanding 2

G06T - Image Data Processing OR Generation, IN General 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

G06N - Computing Arrangements Based ON Specific Computational Models 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

BostonGene Corporation's patent record in context - here's where to go next.

BostonGene Corporation's lead technology class is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology), 76.5% of its portfolio - see every assignee active in that class. Explore G16B
Ranked #9,208 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare BostonGene Corporation against Blue-White Industries, Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.